GCC companion animal medicine market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

GCC Companion Animal Medicine Market, valued at USD 780 million, grows due to increasing pet adoption, health awareness, and tech innovations in the UAE and Saudi Arabia.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAC2382

Pages:85

Published On:October 2025

About the Report

Base Year 2024

GCC Companion Animal Medicine Market Overview

  • The GCC Companion Animal Medicine Market is valued at USD 780 million, based on a five-year historical analysis. This valuation reflects the strong contribution of companion animals within the broader GCC veterinary healthcare sector, where companion animals account for over sixty percent of the total market share in veterinary hospitals and clinics. Growth is primarily driven by rising pet ownership, increased awareness of animal health, and technological advancements in veterinary diagnostics and therapeutics. The demand for high-quality veterinary products and services continues to surge, with a marked shift toward preventive care and wellness for companion animals as pet humanization accelerates across the region .
  • Key players in this market include the UAE and Saudi Arabia, which dominate due to their high pet ownership rates and robust veterinary infrastructure. The UAE has witnessed a significant increase in pet adoption, driven by a growing expatriate population and evolving cultural attitudes toward pet companionship. Saudi Arabia’s expanding urban centers and rising disposable incomes are also fueling demand for companion animal healthcare services, supported by government initiatives to modernize veterinary care .
  • The Executive Regulations for the Practice of Veterinary Medicine and its Professions, issued by the Saudi Food and Drug Authority (SFDA) in 2023, mandate the registration of veterinary clinics and the licensing of veterinary professionals. These regulations set operational standards for veterinary facilities, require compliance with international best practices, and establish penalties for non-compliance, thereby enhancing the quality and safety of veterinary services across Saudi Arabia .
GCC Companion Animal Medicine Market Size

GCC Companion Animal Medicine Market Segmentation

By Type:The market is segmented into Pharmaceuticals, Vaccines, Nutraceuticals, Diagnostics, Medicated Feed Additives, Surgical Instruments, and Others. Each sub-segment addresses diverse health needs of companion animals. Pharmaceuticals remain the largest segment, driven by the increasing prevalence of chronic and infectious diseases among pets and the availability of advanced therapeutics. Vaccines are essential for preventive healthcare, while nutraceuticals are gaining traction as pet owners seek holistic and functional health solutions. Diagnostics are experiencing robust growth, supported by the adoption of in-house diagnostic technologies and AI-driven tools in veterinary clinics .

GCC Companion Animal Medicine Market segmentation by Type.

By End-User:The end-user segmentation includes Veterinary Clinics, Animal Hospitals, Pet Owners, Research Institutions, and Animal Shelters & NGOs. Veterinary Clinics and Animal Hospitals are the primary consumers of companion animal medicine, reflecting the growing number of pet owners seeking professional veterinary care and the expansion of specialized animal healthcare facilities. Pet Owners are increasingly proactive in managing their pets’ health, leading to a rise in direct purchases of medications and health products. Research Institutions and Animal Shelters & NGOs contribute to the adoption of innovative veterinary solutions and public health initiatives .

GCC Companion Animal Medicine Market segmentation by End-User.

GCC Companion Animal Medicine Market Competitive Landscape

The GCC Companion Animal Medicine Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Vetoquinol S.A., IDEXX Laboratories, Inc., Virbac S.A., Covetrus, Inc., Neogen Corporation, PetMed Express, Inc., Trupanion, Inc., Al Ain Farms (UAE), Almarai Veterinary Services (Saudi Arabia), Gulf Veterinary Laboratory (UAE), Al Rawabi Veterinary Division (UAE), Al Hokair Group – Animal Health Division (Saudi Arabia), Al Zahra Veterinary Hospital (UAE), Modern Veterinary Hospital (UAE), Al Barsha Veterinary Clinic (UAE) contribute to innovation, geographic expansion, and service delivery in this space.

Zoetis Inc.

1952

Parsippany-Troy Hills, New Jersey, USA

Merck Animal Health

1891

Rahway, New Jersey, USA

Elanco Animal Health

1954

Greenfield, Indiana, USA

Boehringer Ingelheim Animal Health

1885

Ingelheim am Rhein, Germany

Ceva Santé Animale

1999

Libourne, France

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (GCC region)

Market Penetration Rate (GCC region)

Customer Retention Rate

Product Portfolio Breadth

Pricing Strategy (GCC-specific)

GCC Companion Animal Medicine Market Industry Analysis

Growth Drivers

  • Increasing Pet Ownership:The GCC region has witnessed a significant rise in pet ownership, with over 30 million pets reported in future. This increase is driven by changing lifestyles and urbanization, leading to a greater demand for companion animal healthcare services. The World Bank projects that the GCC's population will grow by approximately 2% annually, further boosting the pet ownership trend. As more households adopt pets, the need for veterinary services and products will continue to expand, driving market growth.
  • Rising Awareness of Animal Health:There is a growing awareness among pet owners regarding the importance of animal health, with 70% of pet owners in the GCC now prioritizing regular veterinary check-ups. This shift is supported by increased access to information through digital platforms and social media. The GCC's healthcare expenditure is projected to reach $100 billion in future, indicating a broader trend towards health consciousness that extends to pets, thereby enhancing the demand for veterinary services.
  • Advancements in Veterinary Medicine:The GCC is experiencing rapid advancements in veterinary medicine, with investments in innovative technologies such as telemedicine and diagnostic tools. In future, the veterinary technology market in the region was valued at approximately $1.5 billion, reflecting a 15% increase from the previous year. These advancements not only improve treatment outcomes but also attract more pet owners seeking high-quality care, thus propelling the companion animal medicine market forward.

Market Challenges

  • High Cost of Veterinary Services:The cost of veterinary services in the GCC can be prohibitively high, with average consultation fees ranging from $50 to $150. This financial barrier limits access to essential healthcare for many pet owners, particularly in lower-income households. As the region's economic growth continues, addressing these costs will be crucial to ensuring that all pet owners can afford necessary veterinary care, impacting overall market growth.
  • Limited Access to Veterinary Care in Rural Areas:Access to veterinary care remains a significant challenge in rural areas of the GCC, where only 40% of rural pet owners have access to veterinary services. This disparity is exacerbated by a lack of infrastructure and qualified professionals in these regions. As urbanization continues, addressing this gap will be essential for ensuring comprehensive animal healthcare across the GCC, impacting the overall market dynamics.

GCC Companion Animal Medicine Market Future Outlook

The GCC companion animal medicine market is poised for significant transformation, driven by technological integration and a shift towards preventive healthcare. As telemedicine and digital health solutions become more prevalent, pet owners will have greater access to veterinary services. Additionally, the increasing focus on pet wellness and preventive care will likely lead to higher demand for innovative veterinary products. These trends indicate a promising future for the market, with opportunities for growth and enhanced pet care services across the region.

Market Opportunities

  • Expansion of Pet Insurance:The pet insurance market in the GCC is expected to grow significantly, with a projected increase from $200 million in future to $500 million in future. This growth will provide pet owners with financial support for veterinary services, encouraging more comprehensive care and preventive measures, ultimately benefiting the overall health of companion animals.
  • Growth in E-commerce for Pet Products:E-commerce for pet products in the GCC is anticipated to reach $1 billion in future, driven by increased online shopping trends. This growth presents opportunities for veterinary practices to expand their services online, offering pet owners convenient access to medications and health products, thereby enhancing customer engagement and loyalty.

Scope of the Report

SegmentSub-Segments
By Type

Pharmaceuticals

Vaccines

Nutraceuticals

Diagnostics

Medicated Feed Additives

Surgical Instruments

Others

By End-User

Veterinary Clinics

Animal Hospitals

Pet Owners

Research Institutions

Animal Shelters & NGOs

By Distribution Channel

Retail

E-commerce

Hospital Pharmacy

Veterinary Clinics

Pharmacies

Direct Sales

By Animal Type

Dogs

Cats

Birds

Small Mammals

Horses

Others

By Region

UAE

Saudi Arabia

Qatar

Kuwait

Oman

Bahrain

By Price Range

Premium

Mid-range

Economy

By Product Formulation

Injectable

Oral

Topical

Others

By Indication

Infectious Diseases

Dermatologic Diseases

Pain Management

Orthopedic Diseases

Behavioral Diseases

Other Indications

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Climate Change and Environment, Saudi Food and Drug Authority)

Manufacturers and Producers

Distributors and Retailers

Veterinary Clinics and Hospitals

Pet Food and Supply Companies

Pharmaceutical Companies

Animal Health Organizations

Players Mentioned in the Report:

Zoetis Inc.

Merck Animal Health

Elanco Animal Health

Boehringer Ingelheim Animal Health

Ceva Sante Animale

Vetoquinol S.A.

IDEXX Laboratories, Inc.

Virbac S.A.

Covetrus, Inc.

Neogen Corporation

PetMed Express, Inc.

Trupanion, Inc.

Al Ain Farms (UAE)

Almarai Veterinary Services (Saudi Arabia)

Gulf Veterinary Laboratory (UAE)

Al Rawabi Veterinary Division (UAE)

Al Hokair Group Animal Health Division (Saudi Arabia)

Al Zahra Veterinary Hospital (UAE)

Modern Veterinary Hospital (UAE)

Al Barsha Veterinary Clinic (UAE)

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. GCC Companion Animal Medicine Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 GCC Companion Animal Medicine Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. GCC Companion Animal Medicine Market Analysis

3.1 Growth Drivers

3.1.1 Increasing Pet Ownership
3.1.2 Rising Awareness of Animal Health
3.1.3 Advancements in Veterinary Medicine
3.1.4 Growth in Disposable Income

3.2 Market Challenges

3.2.1 High Cost of Veterinary Services
3.2.2 Limited Access to Veterinary Care in Rural Areas
3.2.3 Regulatory Hurdles
3.2.4 Competition from Alternative Therapies

3.3 Market Opportunities

3.3.1 Expansion of Pet Insurance
3.3.2 Growth in E-commerce for Pet Products
3.3.3 Increasing Demand for Preventive Care
3.3.4 Development of Innovative Veterinary Products

3.4 Market Trends

3.4.1 Shift Towards Preventive Healthcare
3.4.2 Integration of Technology in Veterinary Practices
3.4.3 Rise of Organic and Natural Pet Products
3.4.4 Increasing Focus on Pet Wellness

3.5 Government Regulation

3.5.1 Veterinary Practice Regulations
3.5.2 Animal Welfare Laws
3.5.3 Import and Export Regulations for Veterinary Products
3.5.4 Licensing Requirements for Veterinary Professionals

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. GCC Companion Animal Medicine Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. GCC Companion Animal Medicine Market Segmentation

8.1 By Type

8.1.1 Pharmaceuticals
8.1.2 Vaccines
8.1.3 Nutraceuticals
8.1.4 Diagnostics
8.1.5 Medicated Feed Additives
8.1.6 Surgical Instruments
8.1.7 Others

8.2 By End-User

8.2.1 Veterinary Clinics
8.2.2 Animal Hospitals
8.2.3 Pet Owners
8.2.4 Research Institutions
8.2.5 Animal Shelters & NGOs

8.3 By Distribution Channel

8.3.1 Retail
8.3.2 E-commerce
8.3.3 Hospital Pharmacy
8.3.4 Veterinary Clinics
8.3.5 Pharmacies
8.3.6 Direct Sales

8.4 By Animal Type

8.4.1 Dogs
8.4.2 Cats
8.4.3 Birds
8.4.4 Small Mammals
8.4.5 Horses
8.4.6 Others

8.5 By Region

8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Kuwait
8.5.5 Oman
8.5.6 Bahrain

8.6 By Price Range

8.6.1 Premium
8.6.2 Mid-range
8.6.3 Economy

8.7 By Product Formulation

8.7.1 Injectable
8.7.2 Oral
8.7.3 Topical
8.7.4 Others

8.8 By Indication

8.8.1 Infectious Diseases
8.8.2 Dermatologic Diseases
8.8.3 Pain Management
8.8.4 Orthopedic Diseases
8.8.5 Behavioral Diseases
8.8.6 Other Indications

9. GCC Companion Animal Medicine Market Competitive Analysis

9.1 Market Share of Key Players

9.2 KPIs for Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (GCC region)
9.2.4 Market Penetration Rate (GCC region)
9.2.5 Customer Retention Rate
9.2.6 Product Portfolio Breadth
9.2.7 Pricing Strategy (GCC-specific)
9.2.8 Distribution Network Coverage (GCC)
9.2.9 R&D Investment Ratio
9.2.10 Regulatory Compliance Score
9.2.11 Brand Recognition Score
9.2.12 Local Partnerships/Presence

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 List of Major Companies

9.5.1 Zoetis Inc.
9.5.2 Merck Animal Health
9.5.3 Elanco Animal Health
9.5.4 Boehringer Ingelheim Animal Health
9.5.5 Ceva Santé Animale
9.5.6 Vetoquinol S.A.
9.5.7 IDEXX Laboratories, Inc.
9.5.8 Virbac S.A.
9.5.9 Covetrus, Inc.
9.5.10 Neogen Corporation
9.5.11 PetMed Express, Inc.
9.5.12 Trupanion, Inc.
9.5.13 Al Ain Farms (UAE)
9.5.14 Almarai Veterinary Services (Saudi Arabia)
9.5.15 Gulf Veterinary Laboratory (UAE)
9.5.16 Al Rawabi Veterinary Division (UAE)
9.5.17 Al Hokair Group – Animal Health Division (Saudi Arabia)
9.5.18 Al Zahra Veterinary Hospital (UAE)
9.5.19 Modern Veterinary Hospital (UAE)
9.5.20 Al Barsha Veterinary Clinic (UAE)

10. GCC Companion Animal Medicine Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Government Veterinary Programs
10.1.2 Public Health Initiatives
10.1.3 Animal Welfare Policies

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Veterinary Facilities
10.2.2 Funding for Animal Health Research

10.3 Pain Point Analysis by End-User Category

10.3.1 Accessibility to Veterinary Services
10.3.2 Affordability of Treatments

10.4 User Readiness for Adoption

10.4.1 Awareness of Veterinary Services
10.4.2 Willingness to Invest in Pet Health

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Effectiveness of Veterinary Treatments
10.5.2 Long-term Health Benefits for Pets

11. GCC Companion Animal Medicine Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Streams Analysis

1.4 Customer Segmentation

1.5 Key Partnerships

1.6 Cost Structure Analysis

1.7 Competitive Advantage


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs

2.3 Target Audience Identification

2.4 Marketing Channels

2.5 Promotional Strategies


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups

3.3 Online Distribution Channels

3.4 Direct Sales Approaches


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis

4.3 Competitor Pricing Strategies


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments Analysis

5.3 Emerging Trends


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service

6.3 Customer Feedback Mechanisms


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains

7.3 Customer-Centric Approaches


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Strategy
9.1.3 Packaging Innovations

9.2 Export Entry Strategy

9.2.1 Target Countries Identification
9.2.2 Compliance Roadmap Development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model Evaluation


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from veterinary associations and pet industry publications
  • Review of government publications and regulations related to animal health and welfare in the GCC
  • Examination of trade statistics and import/export data for companion animal products

Primary Research

  • Interviews with veterinarians and pet care professionals across the GCC region
  • Surveys targeting pet owners to understand spending habits and preferences
  • Focus groups with pet product retailers to gather insights on market trends

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including industry reports and expert opinions
  • Triangulation of market data with sales figures from leading pet product distributors
  • Sanity checks conducted through expert panel reviews comprising veterinarians and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on national pet ownership statistics and average spending per pet
  • Segmentation of the market by product categories such as food, healthcare, and accessories
  • Incorporation of growth rates from regional economic indicators and consumer spending trends

Bottom-up Modeling

  • Collection of sales data from major pet product retailers and veterinary clinics
  • Estimation of market share for key product categories based on firm-level data
  • Volume x price analysis to derive revenue estimates for each segment

Forecasting & Scenario Analysis

  • Utilization of time series analysis to project future market growth based on historical data
  • Scenario modeling based on potential changes in consumer behavior and regulatory impacts
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Clinics60Veterinarians, Clinic Managers
Pet Retailers50Store Owners, Sales Managers
Pet Owners120Dog and Cat Owners, Pet Enthusiasts
Pet Product Manufacturers40Product Development Managers, Marketing Directors
Animal Welfare Organizations40Program Directors, Outreach Coordinators

Frequently Asked Questions

What is the current value of the GCC Companion Animal Medicine Market?

The GCC Companion Animal Medicine Market is valued at approximately USD 780 million, reflecting the significant role of companion animals in the veterinary healthcare sector, which accounts for over sixty percent of the total market share in veterinary hospitals and clinics.

What factors are driving growth in the GCC Companion Animal Medicine Market?

Which countries are the key players in the GCC Companion Animal Medicine Market?

What are the main segments of the GCC Companion Animal Medicine Market?

Other Regional/Country Reports

Indonesia Companion Animal Medicine Market

Malaysia Companion Animal Medicine Market

KSA Companion Animal Medicine Market

APAC Companion Animal Medicine Market

SEA Companion Animal Medicine Market

Vietnam Companion Animal Medicine Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022